Cardiotoxicity  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT01301040: Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Terminated
2
2
Europe
epirubicin, cyclophosphamide, docetaxel, Docetaxel: Taxotere, Cyclophosphamide: Endoxan, Epirubicin: Epirubicin Teva
Jules Bordet Institute, Sanofi
Breast Cancer
03/13
03/16

Download Options